Variant report
Variant | esv275369 |
---|---|
Chromosome Location | chr8:3167898-3170594 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1007010 | chr8:3167898-3167899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs56985209 | chr8:3167902-3167903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs568012283 | chr8:3167929-3167930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116829387 | chr8:3167945-3167946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1566748 | chr8:3167947-3167948 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs60451756 | chr8:3167951-3167952 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs539545959 | chr8:3167952-3167953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190284491 | chr8:3167953-3167954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575849880 | chr8:3167982-3167983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs60661845 | chr8:3167989-3167990 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs561653852 | chr8:3167997-3167998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183194041 | chr8:3168000-3168001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187853709 | chr8:3168009-3168010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192433121 | chr8:3168019-3168020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559732835 | chr8:3168026-3168027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58202270 | chr8:3168029-3168030 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs62504436 | chr8:3168035-3168036 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs563830731 | chr8:3168039-3168040 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62504437 | chr8:3168045-3168046 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs184003822 | chr8:3168046-3168047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567948621 | chr8:3168089-3168090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368913919 | chr8:3168093-3168094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147566107 | chr8:3168095-3168096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535851996 | chr8:3168098-3168099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565689396 | chr8:3168118-3168119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539128884 | chr8:3168123-3168124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143186567 | chr8:3168130-3168131 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148271513 | chr8:3168131-3168132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549247537 | chr8:3168132-3168133 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562955309 | chr8:3168149-3168150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573840332 | chr8:3168151-3168152 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188851438 | chr8:3168153-3168154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs61305119 | chr8:3168156-3168157 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs191979388 | chr8:3168160-3168161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141282417 | chr8:3168161-3168162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370452920 | chr8:3168164-3168165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563766360 | chr8:3168194-3168195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531064800 | chr8:3168196-3168197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113882562 | chr8:3168203-3168204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561493917 | chr8:3168215-3168216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528751509 | chr8:3168216-3168217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547286089 | chr8:3168224-3168225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565500931 | chr8:3168227-3168228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531970637 | chr8:3168231-3168232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551008895 | chr8:3168232-3168233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62504438 | chr8:3168238-3168239 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs571834784 | chr8:3168245-3168246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184355948 | chr8:3168247-3168248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17320243 | chr8:3168264-3168265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188379290 | chr8:3168281-3168282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 19805367 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
Osteosarcoma | 21215367 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3167600-3168000 | Enhancers | Fetal Kidney | kidney |
2 | chr8:3167800-3168400 | Enhancers | Fetal Brain Male | brain |
3 | chr8:3168000-3172400 | Weak transcription | Fetal Kidney | kidney |